<DOC>
	<DOC>NCT01626235</DOC>
	<brief_summary>Study aims to assess patient-recorded outcomes of pain control medications prescribed in the ER after visits for specific painful injuries/illnesses.</brief_summary>
	<brief_title>AMPED Outcomes Registry of Post-ED Pain Management</brief_title>
	<detailed_description>Multicenter, observational, prospective, out-of-hospital registry collecting clinical, satisfaction, quality of life, and healthcare resource utilization from subjects discharged after ED care for a specific acute pain syndrome with a clinician-determined analgesic regimen. Subjects are stratified by diagnosis and by regimen based on the treating clinician's judgment. The registry study is independent of ED care and clinician's decision-making.</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Arthritis, Gouty</mesh_term>
	<mesh_term>Soft Tissue Injuries</mesh_term>
	<mesh_term>Renal Colic</mesh_term>
	<mesh_term>Analgesics, Opioid</mesh_term>
	<criteria>Eligible subjects will meet the following criteria: 1. Eligible diagnoses: musculoskeletal etiologies: acute extremity fractures sprains/strains acute gouty arthritis visceral etiologies: renal colic dysmenorrhea 2. Age GTE 18 years; 3. Decision to discharge from ED to community already made; 4. Decision to give SPRIX, opioid, OR SPRIX + opioid rescue already made; 5. Treating clinician deems patient appropriate for continued analgesic management as an outpatient for the next 35 days; 6. Patient has ready touchtone (mobile or land line) telephone access, provides number (and backup number, if possible) and agrees (verbal or written consent as mandated by site) to answer and comply with brief IVR questionnaires daily for next 4 days. Eligible subjects will meet none of the following criteria: 1. Patient admitted or placed on observation status from ED; 2. Patient unwilling or unable to comply with telephonic followup; 3. Fracture that requires surgical repair (even if at a later date); 4. Patient has diagnosis of any chronic pain syndrome; 5. Patient already routinely takes NSAID or opioid agent; 6. Treating clinician has reasonable suspicion of drugseeking behavior or noncompliance; 7. Nasal abnormality or illness that could affect the absorption of intranasal medication (such as: nasal discharge, rhinitis, acute upper respiratory infection, acute epistaxis, nasal polyp, nasal tumor).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>pain control</keyword>
	<keyword>fractures</keyword>
	<keyword>sprains</keyword>
	<keyword>strains</keyword>
	<keyword>dysmenorrhea</keyword>
	<keyword>kidney stones</keyword>
	<keyword>gouty arthritis</keyword>
	<keyword>opioids</keyword>
	<keyword>NSDAIDs</keyword>
	<keyword>Emergency Department</keyword>
	<keyword>patient reported outcomes</keyword>
</DOC>